top of page

Rubix LS Joins CancerX As A Founding Member

On Friday, June 2, 2023, at ASCO, CancerX – a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH) – announced its founding members:

  1. 1104Health

  2. AARDEX Group

  3. Amazon Web Services (AWS)

  4. American Cancer Society

  5. ASCO CancerLinQ

  6. AstraZeneca

  7. Athelo Health

  8. Atrium Health Wake Forest Baptist Comprehensive Cancer Center

  9. Atrium Health Levine Cancer Institute

  10. Autonomize, Inc.

  11. Avellino

  12. Banner MD Anderson Cancer Center

  13. Biofourmis

  14. Biohacking Village

  15. Blue Note Therapeutics

  16. Blue Spark Technologies, Inc.

  17. Bulldog Medical, Inc.

  18. C the Signs

  19. Canadian Cancer Society

  20. Cancer Support Community

  21. Carium

  22. City of Hope

  23. Clario

  24. Current Health, A Best Buy Health Company

  25. Dana-Farber Cancer Institute

  26. Datavant

  27. Elevance Health

  28. Emerson Collective Health

  29. Empatica

  30. Family Reach

  31. Flatiron Health

  32. Foley & Lardner LLP

  33. Folia Health

  34. Genentech, a member of the Roche group

  35. Genomate Health

  36. Graphite Health

  37. Gray Oncology Solutions

  38. Haystack Health

  39. Health Chain

  40. Health Wallet

  41. Hike Health

  42. HunterSeven Foundation

  43. Hurone AI

  44. Intel

  45. Jasper Health

  46. Kaiser Permanente

  47. Leukemia & Lymphoma Society

  48. Light Collective

  49. Lightship Inc

  50. Lunit

  51. Luscii

  52. MassChallenge

  53. Massive Bio

  54. MD Anderson

  55. Medable

  56. MEND Nutrition

  57. Memorial Sloan Kettering Cancer Center (MSK)

  58. Navio Theragnostics, Inc.

  59. National Cancer Institute (NCI)

  60. NorthShore—Edward-Elmhurst Health

  61. OncoPower

  62. Oracle

  63. Orchid Healthcare Solutions

  64. Outcomes4Me

  65. Pluto Health

  66. Point32Health Inc

  67. Power

  68. Qritive Pte Ltd

  69. RestAssured MD

  70. Rubix LS

  71. Savvy Cooperative

  72. Science 37

  73. Sidekick Health

  74. Siemens Healthineers

  75. SimBioSys, Inc.

  76. Slope

  77. Socially Determined

  78. Sophia Genetics

  79. Soteria

  80. State of Colorado

  81. Takeda

  82. Takeda Digital Ventures

  83. Tempus

  84. The Janssen Pharmaceutical Companies of Johnson & Johnson

  85. Thyme Care

  86. Touch BBCA

  87. Tulsa Innovation Labs (TIL)

  88. UC Davis Health

  89. UChicago Medicine

  90. Veris Health

  91. VivoSense

  92. Volpara Health

  93. This group will drive the success of CancerX, collaborating to set priorities and practices that will help us harness the full power of innovation to achieve the goals of the Cancer Moonshot.

  94. Thursday, May 25, ASCO also published two online abstracts from CancerX:

  95. CancerX: A national public-private partnership to boost innovation in the fight against cancer,” which outlines CancerX’s multi-pronged approach focused on 1) commoditizing best practices and aligning incentives, 2) coordinating access to research, mentorship, resources, and other collaborative opportunities, and 3) demonstrating success in practice to drive broad adoption – all the achieve the goal of reducing the incidence and burden of cancer for all people.

  96. Advancing digital innovation to improve equity and reduce financial toxicity in cancer treatment,” which details CancerX’s inaugural project to define the value of digital innovation in cancer treatment, address methodological and implementation gaps, and develop best practices for equitable adoption of digital health technologies at scale in precision oncology.

Background on CancerX:

  1. CancerX was announced by U.S. President Joe Biden and Dr. Jill Biden in February 2023 as part of The White House’s reignited national Cancer Moonshot initiative.

  2. The public-private partnership unites the diverse stakeholders and innovators necessary to unleash the power of digital innovation to design and create a future that’s free of the burden of cancer.

  3. At the end of March 2023, CancerX announced its co-hosts: Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH). It also announced its inaugural project, “Advancing Digital Innovation to Improve Equity and Reduce Financial Toxicity in Cancer Care and Research,” which has begun work to assess, quantify, and enhance the impact of digital solutions on cancer care cost, access, and outcomes dimensions.

  4. Sign up to receive information on this news and other CancerX work.



bottom of page